Global Genomics Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In November 2023, Fabric Genomics collaborated with DNAnexus and Oxford Nanopore Technologies for deployment of CLIA/CAP labs in pediatric and neonatal ICU’s. The labs will use Oxford Nanopore’s platforms to study genetic disorders in infants.

• In February 2023, Illumina, Inc. entered into a collaboration with African Centre of Excellence for Genomics of Infectious Diseases to start a training institute to increase genomic capabilities in African region

• In January 2023, SOPHiA GENETIC collaborated with the Memorial Sloan Kettering Cancer Center (MSK), a U.S. Cancer Center, to offer researchers and clinicians solutions to expand analytical and testing capabilities.

• In January 2023, Agilent Technologies, Inc. announced acquisition of Avida Biomed, a company that develops target enrichment workflows for clinical researchers utilizing NGS methods to study cancers.

• In April 2022, QIAGEN launched the Biomedical Knowledge Base in Europe, Japan, North America, and Australia to support data science applications in biotech companies

In terms of Technology, the genomics market encompasses a wide array of innovative approaches and methodologies aimed at studying the structure, function, and evolution of genomes. Key segments within this category include sequencing technologies, microarray analysis, polymerase chain reaction (PCR), and nucleic acid extraction. Next-generation sequencing (NGS) technologies, such as Illumina sequencing platforms and Oxford Nanopore sequencing, have revolutionized genomic research by enabling high-throughput sequencing at reduced costs and enhanced accuracy. Additionally, advancements in single-cell genomics and CRISPR-based genome editing techniques have expanded the scope of genomic research, unlocking new opportunities for precision medicine and personalized healthcare.

Deliverables in the genomics market refer to the tangible outcomes or products generated through genomic analysis and research. These include genomic data analysis software, sequencing kits and reagents, clinical and research services, and consumables. With the increasing demand for genomic testing in various applications, including diagnostics, drug discovery, agriculture, and forensics, the market for genomic deliverables is experiencing robust growth. Companies offering comprehensive genomic solutions, such as integrated sequencing platforms coupled with bioinformatics software, are poised to capitalize on this growing demand and drive innovation in the market.

Global Genomics Segment Analysis

In this report, the Global Genomics Market has been segmented by Technology, Deliverables and Geography.

Global Genomics Market, Segmentation by Technology

The Global Genomics Market has been segmented by Technology into Sequencing, PCR, Flow Cytometry, Microarrays and Others.

Polymerase Chain Reaction (PCR) represents another crucial technology segment, playing a pivotal role in amplifying specific DNA sequences for various applications such as genetic testing, infectious disease diagnosis, and forensic analysis. The versatility and sensitivity of PCR have made it indispensable in both research and clinical settings, contributing significantly to the expansion of the genomics market.

Flow cytometry, an analytical technique used to measure and analyze the physical and chemical characteristics of cells or particles, is also a prominent technology in genomics. Flow cytometry enables the identification and sorting of cells based on their DNA content, gene expression, and protein markers, facilitating research in immunology, cancer biology, and stem cell research. Microarrays, a powerful tool for analyzing gene expression and detecting genetic variations, have found widespread applications in genomics research, diagnostics, and personalized medicine. Microarray technology enables the simultaneous analysis of thousands of genes or genetic variations, providing valuable insights into disease mechanisms, biomarker discovery, and drug response profiling.

The genomics market encompasses a diverse array of other methodologies and tools, including bioinformatics, gene editing technologies such as CRISPR-Cas9, and emerging single-cell genomics techniques. These technologies collectively drive innovation and discovery in genomics, fueling advancements in precision medicine, agricultural biotechnology, and synthetic biology.

Global Genomics Market, Segmentation by Deliverables

The Global Genomics Market has been segmented by Deliverables into Products and Services.

Within the genomics market, products encompass a wide array of tools and technologies designed to analyze, manipulate, and interpret genetic information. This segment includes instruments such as sequencers, microarrays, and PCR machines, which are essential for DNA sequencing, genotyping, and gene expression analysis. Advances in product development have led to the emergence of next-generation sequencing (NGS) platforms, enabling rapid and cost-effective whole-genome sequencing.

Reagents and consumables form a significant portion of the genomics product market, providing essential components for sample preparation, DNA amplification, and analysis. These consumables include nucleic acid extraction kits, sequencing libraries, and polymerase chain reaction (PCR) reagents, supporting various genomic applications. Complementary to genomics products, the services segment offers a range of specialized solutions to meet the diverse needs of researchers, clinicians, and biotechnology companies. Genomics services encompass sequencing services, bioinformatics analysis, and genetic testing. Sequencing services provide access to high-throughput sequencing technologies, allowing researchers to outsource large-scale genomic projects and obtain comprehensive DNA sequence data.

Global Genomics Market, Segmentation by Geography

In this report, the Global Genomics Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Genomics Market Share (%), by Geographical Region, 2024

North America, comprising the United States and Canada, dominates the global genomics market due to its robust healthcare infrastructure, presence of major genomics companies, and substantial investments in research and development. The region is witnessing rapid adoption of genomic technologies in clinical diagnostics, personalized medicine, and drug discovery, supported by favorable government initiatives and collaborations between academia and industry.

Europe, encompassing countries like the United Kingdom, Germany, France, and others, is another prominent market for genomics. The region boasts a strong research ecosystem, with renowned academic institutions and biotechnology hubs driving innovation in genomics. Increased focus on precision medicine, genomic testing, and initiatives such as the European Union's Horizon 2020 program are fueling market growth in Europe.

Asia Pacific emerges as a lucrative market for genomics, propelled by rising healthcare expenditure, expanding biotechnology sector, and growing awareness about genomic technologies. Countries like China, Japan, and India are witnessing significant investments in genomics research, driven by government initiatives, academic collaborations, and the presence of key market players. The region's large population base and increasing prevalence of chronic diseases further contribute to market expansion.

The Middle East and Africa region is gradually embracing genomics, albeit at a slower pace compared to other regions. Factors such as improving healthcare infrastructure, rising disease burden, and government initiatives to promote genomics research are driving market growth in select countries. However, challenges related to healthcare access, regulatory frameworks, and infrastructure limitations pose barriers to market development in certain parts of the region.

Latin America represents a growing market opportunity for genomics, fueled by increasing adoption of precision medicine, genomic research initiatives, and collaborations with international genomics organizations. Countries like Brazil, Mexico, and Argentina are at the forefront of genomics adoption, driven by advancements in biotechnology, supportive government policies, and rising demand for personalized healthcare solutions.